Influences of Buyi Qiangxin Tablets on Cardiac Function and Life Quality of Chronic Heart Failuture Patients

GAO Zi-ren; SUI Dian-jun; LI Kun

doi:10.11653/syfj2013210298

您当前的位置：

首页 >

文章列表页 >

Influences of Buyi Qiangxin Tablets on Cardiac Function and Life Quality of Chronic Heart Failuture Patients

更新时间：2024-01-04

- Influences of Buyi Qiangxin Tablets on Cardiac Function and Life Quality of Chronic Heart Failuture Patients
- Chinese Journal of Experimental Traditional Medical Formulae Vol. 19, Issue 21, Pages: 298-301(2013)
- 作者机构：
- 作者简介：
- 基金信息：
- DOI：10.11653/syfj2013210298
  CLC：
- Published：2013
- 稿件说明：
移动端阅览
GAO Zi-ren, SUI Dian-jun, LI Kun. Influences of Buyi Qiangxin Tablets on Cardiac Function and Life Quality of Chronic Heart Failuture Patients[J]. Chinese journal of experimental traditional medical formulae, 2013, 19(21): 298-301.
DOI：

GAO Zi-ren, SUI Dian-jun, LI Kun. Influences of Buyi Qiangxin Tablets on Cardiac Function and Life Quality of Chronic Heart Failuture Patients[J]. Chinese journal of experimental traditional medical formulae, 2013, 19(21): 298-301. DOI： 10.11653/syfj2013210298.

摘要

目的: 探讨补益强心片对慢性心力衰竭(CHF)患者心功能和生活质量的影响。方法: 将68例CHF患者随机按住院前后分为对照组和观察组各34例。两组均参照"慢性心力衰竭诊断治疗指南"给予心衰一般治疗和西药常规治疗。观察组加用补益强心片

1.2 g/次

3次/d。疗程4周。评价治疗前后美国纽约心脏病协会(NYHA)心功能分级和6 min步行实验(6 MWT)

记录Lee氏心衰计分

采用超声心动图测定心室射血分数(LVEF)和心输出量(CO)

以明尼苏达心衰生活质量调查表评估生活质量

检测血浆脑钠素前体末端(NT-proBNP)和抗利尿激素(ADH)水平。结果: 观察组Lee氏心衰疗效总有效率为91.17%

优于对照组的73.52% (P<0.05);观察组心功能分级疗效总有效率为88.23%

优于对照组的67.64% (P<0.05);观察组治疗后Lee氏心衰积分和生活质量评分均较治疗前下降

并低于对照组(P<0.01);两组治疗后6 MWT均比治疗前增加

观察组增加更为显著(P<0.01);治疗后两组LVEF和CO均上升

观察组高于对照组(P<0.01);观察组治疗后血浆NT-proBNP和ADH水平均比治疗前下降

并低于对照组(P<0.01)。结论: 补益强心片能改善CHF患者心功能分级

提高LVEF和CO

增加患者6MWT

提高患者生活质量

其作用机制可能与降低患者血浆NT-proBNP和ADH水平有关。

Abstract

Objective: To study the influences of Buyi Qiangxin tablet on cardiac function and life quality of the chronic heart failure (CHF) patients. Method: Sixty-eight cases of patients with CHF were randomly divided into control group (34 cases) and observation group (34 cases)according to before and after entering the hospital. The patients of both groups took general treatment of cardiac failure and conventional western medical treatment according to the guide of the diagnosis and treatment of chronic heart failure. The patients in observation group took Buyi Qiangxin tablets

1.2 g/time

3 times/day

the treatment course is 4 weeks. The New York Heart Association (NYHA) cardiac heart grading and 6 minutes walk test (6 MWT) were evaluated before and after treatment

recording Lee's heart failure. Left ventricular ejection fraction (LVEF) and cardiac output (CO) were tested using echocardiography. The life quality was evaluated by Minnesota life quality of heart failure questionnaires. detecting the plasma NT-proBNP and antidiuretic hormone (ADH) level. Result: The total curative effect of Lee's heart failure of the observation group was 91.17%

which is higher than that of the control group (73.52%

P<0.05). The total curative effect of cardiac function of observation was 88.23%

superior to 67.64% in the control group (P<0.05). After the treatment

the Lee's heart failure points and life quality scores of observation group decreased and were lower than the control group (P<0.01). The 6MWT of both groups increased and the increasing in observation group was more significantly (P<0.01). The LVEF and CO of both groups increased after the treatment

the observation group was higher than control group (P<0.01). The levels of plasma NT-proBNP and ADH decreased and observation group was less than the control group (P<0.01). Conclusion: Buyi Qiangxin tablets can improve cardiac function grading of CHF patients

increasing LVEF

6 MWT and life quality of patients. Its mechanism may be related to decreasing NT-proBNP and ADH of patients.

关键词

Keywords

references

Views

下载量

CSCD

Alert me when the article has been cited

提交

Tools

Publicity Resources

Impacts of Yiqi Huoxue Decoction on Cardiac Function and Life Quality in Patients with Qi-deficiency and Blood Stasis Syndrome in Chronic Heart Failure

Protective Effect of Shengxiantang on Myocardial Microvascular Injury in Rats with Chronic Heart Failure

Effect of Yiqi Wenyang Huoxue Lishui Components on Cardiac Function and Mitochondrial Energy Metabolism in CHF Rats

Related Author

ZHANG Ming-li

JIANG Rui-xue

GAO Hui

YANG Zeqi

GAO Fan

LI Hongjing

LU Aiyangzi

LIU Xingchao

Related Institution

Hebei University of Chinese Medicine

Hebei Provincial Hospital of Traditional Chinese Medicine（TCM）

Hebei Technology Innovation Center for TCM Formula Preparations

Hebei Higher Education Institute Applied Technology Research Center for TCM Development and Industrialization

Hebei Higher Education Institute Applied Technology Research Center on TCM Development and Industrialization

AI问答

Postal code：100700
Tel：010-84076882 Email：syfjx_2010@188.com
Technical support is provided by Beijing Founder electronics co., LTD 京ICP备11006657号-10 京公网安备11010802024621
It is recommended to read the content of this site in Chrome&IE9+. Please switch to extreme mode in browser 360.
Cookies We use cookies to help provide and enhance our service and tailor content. By continuing, you agree to the use of cookies.

⁰